Emerging treatments for postmenopausal osteoporosis – focus on denosumab
Piet GeusensDepartment of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands and Biomedical Research Institute, University Hasselt, BelgiumAbstract: The pathway of the receptor activator of the nuclear factor κB ligand (RANKL),...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2009
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4cf8c096344043bb8ebe89a9ae1dbba8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|